Repositioning metformin and propranolol for colorectal and triple negative breast cancers treatment

Abstract Drug repositioning refers to new uses for existing drugs outside the scope of the original medical indications. This approach fastens the process of drug development allowing finding effective drugs with reduced side effects and lower costs. Colorectal cancer (CRC) is often diagnosed at adv...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: L. E. Anselmino, M. V. Baglioni, F. Malizia, N. Cesatti Laluce, C. Borini Etichetti, V. L. Martínez Marignac, V. Rozados, O. G. Scharovsky, J. Girardini, M. J. Rico, M. Menacho Márquez
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/93cfc863cbba48eda474cd3a9008e6b4
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!